The Precious Metals Sector 'Tips Its Hand'
Source: Clive Maund for The Gold Report  (3/3/17)
It is common for commodities to drop in unison, says technical analyst Clive Maund, and in tandem with his prediction that oil will drop, he also sees gold and silver going lower. More >

Inflation, the Dollar and Gold
Source: Rudi Fronk and Jim Anthony for The Gold Report  (3/3/17)
Rudi Fronk and Jim Anthony, co-founders of Seabridge Gold, discuss anticipated interest rate action by the Fed and its possible effect on gold. More >

Broadway Gold Ramps Up Exploration at Madison Mine
Source: The Gold Report  (3/2/17)
Broadway Gold Mining has recently begun both surface and underground mining at its Madison Mine, advancing exploration at the historic gold-copper project in the Butte-Anaconda mining district of Montana and netting the attention of industry watchers. More >

Alkane Is in Position to Benefit from Hafnium Demand Rise
Source: The Gold Report  (3/2/17)
Hafnium may not be a household word, but demand for the element is growing, and Alkane Resources is gearing up to take advantage. More >

Stellar Biotechnologies (SBOT:NASDAQ) Inks Multiyear KLH Supply Agreement with Amaran Biotechnology; Stellar Up 13% on News
Source: The Life Sciences Report  (3/2/17)
Stellar Biotechnologies and Amaran Biotechnology have entered into an exclusive agreement where Stellar will supply KLH to the biopharmaceuticals manufacturer. More >

Stellar Biotechnologies (SBOT:NASDAQ) Could Rise with KLH Vaccine Trial Success
Source: Jason McCarthy for The Life Sciences Report  (3/1/17)
Several KLH-based vaccines are in trials for indications as varied as breast cancer and lupus, and clinical success could propel Stellar Biotechnologies, which is the only provider of KLH that has its own aquaculture facilities, says Jason McCarthy, an equity research analyst with Maxim Securities. Maxim currently has a price target of $4 on Stellar and the stock currently trades at around $1.65. More >

Irving Resources, Tightest Shares in Canada
Source: Bob Moriarty for The Gold Report  (3/1/17)
Bob Moriarty of 321 Gold discusses Irving Resources, a spinoff from Gold Canyon Resources that has assets in northern Japan. More >

The Fantasy Continues
Source: Rudi Fronk and Jim Anthony for The Gold Report  (3/1/17)
Rudi Fronk and Jim Anthony, co-founders of Seabridge Gold, assess President Donald Trump's speech to a joint session of Congress and find it wanting. More >

Three Outstanding Opportunities in the Natural Resources Sector
Source: Matt Geiger for The Gold Report  (2/28/17)
Aside from the exuberance surrounding the tops of bull markets, the general investment public is uninterested and underinvested in natural resource equities, says Matt Geiger, founder of MJG Capital Limited Partners. Geiger views the general apathy toward natural resources as an opportunity, and profiles three companies that he believes are in position to break away from the herd. More >

Millennium Minerals, an Accident Waiting to Happen
Source: Bob Moriarty for The Gold Report  (2/28/17)
Bob Moriarty of 321 Gold dissects Millennium Minerals' latest moves in Australia. More >

Canada Zinc: Right Time, Right Metal
Source: Bob Moriarty for The Gold Report  (2/27/17)
321 Gold founder Bob Moriarty turns his attention to Canada Zinc, a company that has a giant zinc deposit in northern British Columbia. More >

Oil Prices Surge and Investors Become Bullish in Wake of OPEC Deal
Source: The Energy Report  (2/27/17)
With OPEC producers complying with a deal to reduce output to address the oil glut that drove prices down in 2016, the oil price has rebounded above $55 per barrel, and investors are optimistic about a bullish energy market. More >

Pretium Resources Adds Capital to Brucejack's Accelerated Operations Schedule
Source: The Gold Report  (2/27/17)
Pretium Resources is ramping up Brucejack ahead of schedule and the $100 million offering the company just closed will fund working capital requirements for its start-up. More >

Major Funds Betting On Trump Sector
Source: Tom Beck for The Life Sciences Report  (2/25/17)
Donald Trump's presidency is a real nitro boost for the future of the biotech sector in the U.S., says Tom Beck, editor of Portfolio Wealth Global. More >

Jack Chan's Weekly Gold and Silver Update
Source: Jack Chan for The Gold Report  (2/25/17)
Technical analyst Jack Chan charts the latest moves in the gold and silver sectors. More >

Chevrier Gold Project: A New District-Scale Start with Lots of Upside for Genesis Metals
Source: The Critical Investor for The Gold Report  (2/24/17)
The Critical Investor takes an in-depth look at Genesis Metals, which is developing a new geologic model for its 100%-owned flagship Chevrier Gold deposit in Quebec. More >

GFG Resources Secures Financing to Stoke Rattlesnake Hills Gold Project
Source: The Gold Report  (2/23/17)
GFG Resources has closed a CA$5 million bought-deal financing, securing funding for ongoing exploration at its flagship Rattlesnake Hills gold project in Wyoming. More >

Energy Fuels Provides 'Strong Leverage to Potentially Increasing Uranium Prices'
Source: The Energy Report  (2/23/17)
Uranium has risen 30% from the very low prices of late last year and a trio of analysts agrees that Energy Fuels is in position to take advantage of a rising price environment. More >

The Discoveries Keep on Coming for Balmoral Resources
Source: The Gold Report  (2/23/17)
Balmoral's string of assay results released over the last few weeks includes new discoveries as well as extensions of high-grade zones on its Quebec properties. More >

Seabridge Gold Ups the Ante with Nevada Acquisition Deal and Updated Resource at Deep Kerr
Source: The Gold Report  (2/23/17)
Seabridge Gold's recent announcement of an increased resource estimate at its KSM project caught the attention of one analyst, and follows another announcement that the company intends to purchase a project that potentially intersects three of Nevada's well-known gold trends. More >

Buckle Up: Inflation at 58-Month High
Source: Lior Gantz for The Gold Report  (2/23/17)
The stage has been set for high levels of uncertainly, and with uncertainty comes opportunities in commodities, posits Lior Gantz, editor of Wealth Research Group, who also sees opportunities in disruptive technologies in the medical arena. More >

RXi-MirImmune Merger Aims to Unlock Value Through Groundbreaking Technology
Source: The Life Sciences Report  (2/22/17)
RXi Pharmaceuticals' proprietary self-delivering RNAi (sd-rxRNA) platform offers efficient delivery to cells ex vivo, an application with tremendous potential in immuno-oncology. It's no surprise then that RXi has acquired MirImmune, a company that has been focusing on the next generation of immunotherapies for the treatment of cancer. In this interview with The Life Sciences Report, Geert Cauwenbergh, RXi's President and CEO; Alexey Eliseev, Chief Business Officer; and Pam Pavco, Chief Development Officer, discuss their technologies, the merger and why they believe that in 10 years pure chemotherapy could be relegated to the treatment of last resort. More >

Viveve Medical Posts Record Revenues and Analysts Foresee Continued Growth
Source: The Life Sciences Report  (2/22/17)
As Viveve Medical ramped up its U.S. sales force, reported record earnings, increased the number of countries that have given regulatory approval and saw the results of its VIVEVE I clinical study published in the Journal of Sexual Medicine, a trio of analysts took notice. More >

Atlantic Gold: Constructing MRC Is Just the Start of This Growth Story
Source: The Critical Investor for The Gold Report  (2/21/17)
The Critical Investor profiles Atlantic Gold, which expects to commission its Moose River gold mine in Nova Scotia by the end of this year. More >

Jack Chan: Buy Zones in an Oil Bull Market
Source: Jack Chan for The Energy Report  (2/18/17)
Technical analyst Jack Chan charts the latest moves in energy market, noting a major buy signal. More >